Skip to content
HackedAlive
Research. Verification. Longevity
Menu
Menu
Home
Peptides
Nootropics
Longevity
Research
Vendor Transparency
Category: Neurochemistry
{compound}: Research Intelligence Overview
The AICAR Paradox: Why the ‘Exercise Pill’ Fails to Cross the Rodent-to-Human Gap
Selank vs N-Acetyl Selank Amidate: Stability, BBB Penetration, and the Evidence Gap
The Piracetam Paradox: Why the Original Nootropic Still Lacks Healthy-User Data
2025 Semax & N-Acetyl Semax Research Report: Data, Mechanisms, and the Human Translation Gap
2025 Delta Sleep-Inducing Peptide (DSIP) Data Report: Analyzing the Gap Between Mechanisms and Human Outcomes
IN THIS ARTICLE
×
Mechanism of action: How melanocortin agonists bypass the heart
PT-141 for women: Analyzing the RECONNECT data
Clinical efficacy: The 8% gap
Dosing protocols used in trials
The Vyleesi gap versus experimental peptides
PT-141 for men: Beyond the vascular approach
The side effect profile: Navigating the 40% nausea threshold
Vendor transparency and verification frameworks
Key Takeaways
←
TOC